Mahasweta Gooptu, MD discusses results from the NMDP-sponsored access expansion Study

Phase 2 Study of post transplant cyclophosphamide-based graft versus host disease prophlaxis after HLA-mismatched unrelated donor transplantation and reduced intensity conditioning